Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Find out which retirement plan is best for you at 55. Identify your perfect financial fit for a secure future.
25,133 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
An 8% jump can feel exciting, but a smart investor asks: what’s next? This guide breaks down how to assess a sudden m...
When a prominent fund makes a sizable stake reduction, it often signals more than profit-taking. This article breaks ...
Dreaming of owning a sports team? This guide explains how everyday investors can participate in the sports ecosystem,...
The race to commercialize solid-state batteries is accelerating, and QuantumScape sits at the center. This deep dive ...
A dramatic 41% weekly jump has investors buzzing about Infleqtion. Learn what fueled the move, how to evaluate quantu...
A British TikTok star is entangled in a Dubai murder case, raising questions about legal costs, travel insurance, and...
Abra aims to go public on Nasdaq through a SPAC valued at about $750 million. This move blends traditional markets wi...
Oasis Management revealed a sizable new stake in Vail Resorts, boosting its position by 237,162 shares in Q1. This ar...
Costco reports stronger quarterly results as its $250 billion expansion strategy accelerates, supported by a robust m...
Palantir has a large revenue backlog, a major Army contract on the books, and ambitious growth guidance. This analysi...
AMD has delivered a staggering run, rising nearly 300% over past year. This article breaks down whether the momentum ...